AZO GANTANOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Azo Gantanol, and what generic alternatives are available?
Azo Gantanol is a drug marketed by Roche and is included in one NDA.
The generic ingredient in AZO GANTANOL is phenazopyridine hydrochloride; sulfamethoxazole. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole profile page.
Summary for AZO GANTANOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AZO GANTANOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AZO GANTANOL
US Patents and Regulatory Information for AZO GANTANOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | AZO GANTANOL | phenazopyridine hydrochloride; sulfamethoxazole | TABLET;ORAL | 013294-001 | Sep 10, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
